Sarina Tanimoto
Fondatore presso ARS PHARMACEUTICALS, INC.
Patrimonio netto: 40 M $ in data 30/04/2024
Provenienza dei contatti di primo grado di Sarina Tanimoto
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 18 | |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sarina Tanimoto tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Recros Medica, Inc.
Recros Medica, Inc. Medical SpecialtiesHealth Technology Recros Medica, Inc. is a clinical stage medical device company, which engages in the research and development of aesthetic products to enhance appearance. Its product called Nuvellus Focal Contouring System is use by dermatologists, plastic surgeons, and other aesthetic physicians to reduce skin laxity, enhance focal aesthetic contouring, and provide a natural alternative to commercial dermal fillers. The company was founded by Edward Knowlton, David F. Hale, and Cathy L. McCarthy in 2014 and is headquartered in San Diego, CA. | Medical Specialties | Director of Finance/CFO | |
MDRejuvena, Inc.
MDRejuvena, Inc. Pharmaceuticals: MajorHealth Technology MDRejuvena, Inc. manufactures skin care products. It specializes in providing products that rejuvenate, enhance and maintain skin health for the patients of physicians and skincare professionals worldwide. The company was founded by David F. Hale in 2013 and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
DERMATA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree | |
SYNTHORX, INC. | Biotechnology | Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Somerset Pharmaceuticals, Inc.
Somerset Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Somerset Pharmaceuticals, Inc. is a company that manufactures pharmaceutical products. The company is based in Tampa, FL. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Founder Director/Board Member | |
University of San Diego | College/University | Graduate Degree Graduate Degree | |
YMCA of San Diego County
YMCA of San Diego County Services to the Health IndustryHealth Services YMCA of San Diego County operates as a non-profit organization that offers enrichment programs. It focuses in the areas of youth development, healthy living, and social responsibility. The company was founded by George Marston in 1882 and is headquartered in San Diego, CA. | Services to the Health Industry | Director/Board Member Chairman | |
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of California, Los Angeles | College/University | Undergraduate Degree | |
RA Capital Advisors LLC
RA Capital Advisors LLC Investment Banks/BrokersFinance RA Capital Advisors LLC provides investment banking and financial advisory services. It specializes in mergers and acquisitions, private financing, shareholder matters, restructurings and crisis situations. RA Capital Advisors was founded in 1988 and is headquartered in San Diego, CA. | Investment Banks/Brokers | Corporate Officer/Principal | |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | Miscellaneous Commercial Services | Chief Executive Officer | |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Hale BioPharma Ventures LLC
Hale BioPharma Ventures LLC BiotechnologyHealth Technology Hale BioPharma Ventures LLC develops and produces biopharmaceutical products. The private company is based in Encinitas, CA. David F. Hale has been the CEO of the company since 2006. | Biotechnology | Corporate Officer/Principal | |
VERENIUM CORP | Biotechnology | General Counsel | |
Latham & Watkins LLP
Latham & Watkins LLP Miscellaneous Commercial ServicesCommercial Services Latham & Watkins LLP operates as a full-service law firm or legal matters. It offers services in the areas of finance, litigation, accounting, banking, life sciences, private equity, real estate, government relations, employment law, and outsourcing. The company was founded in 1934 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of California, Berkeley | College/University | Graduate Degree | |
Georgetown University | College/University | Undergraduate Degree | |
Adigica Health, Inc.
Adigica Health, Inc. Pharmaceuticals: MajorHealth Technology Adigica Health, Inc. engages in the development and commercialization of proprietary healthcare products directly to consumers. It offers BioClarity, a plant-based skincare product for teenagers and young adults. The company was founded by Frederick G. Sliter III and David F. Hale in 2016 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Biotechnology | Director/Board Member | |
Corporate Directors Forum
Corporate Directors Forum Miscellaneous Commercial ServicesCommercial Services Corporate Directors Forum operates as a forum for corporate directors. The non-profit company is based in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Zerigo Health, Inc.
Zerigo Health, Inc. Medical SpecialtiesHealth Technology Zerigo Health, Inc. develops handheld ultra violet device. It offers therapy to psoriasis, eczema, and vitiligo patients. The company was founded by Martyn Gross and Remo Qajar in 2014 and is headquartered in San Diego, CA. | Medical Specialties | Director of Finance/CFO | |
ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NKARTA, INC. | Biotechnology | Director/Board Member | |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Corporate Officer/Principal | |
RELAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
Gennao Bio, Inc.
Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 45 |
Svizzera | 3 |
Francia | 2 |
Regno Unito | 2 |
Settori
Health Technology | 27 |
Commercial Services | 10 |
Consumer Services | 8 |
Finance | 4 |
Health Services | 2 |
Posizioni
Director/Board Member | 185 |
Corporate Officer/Principal | 65 |
Independent Dir/Board Member | 55 |
Chief Executive Officer | 31 |
Founder | 27 |
Contatti più connessi
Insiders | |
---|---|
Jonathan Leff | 45 |
Peter Thompson | 39 |
Brenton Saunders | 38 |
Peter Kolchinsky | 32 |
Rajeev Dadoo | 24 |
Brian Dorsey | 22 |
Kathleen Scott | 21 |
Pratik Shah | 18 |
Laura Shawver | 18 |
Saqib Islam | 15 |
Phillip Schneider | 14 |
Richard Lowenthal | 13 |
Michael Kelly | 12 |
Alexander Fitzpatrick | 11 |
Justin Chakma | 9 |
- Borsa valori
- Insiders
- Sarina Tanimoto
- Connessioni Società